1.Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway

Li, X, Fan, XX, Jian     More...

Li, X, Fan, XX, Jiang, ZB, Loo, WTY, Yao, XJ, Leung, ELH, Chow, LWC, Liu, L     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2017, Volume 115, Pages 45-55

收錄情况： WOS SCOPUS

WOS核心合集引用: 79  2024影響因子:  10.5  发表年影響因子:  4.897 

2.Cordycepin Inhibits Drug-resistance Non-small Cell Lung Cancer Progression by Activating AMPK Signaling Pathway

Wei, CL, Yao, XJ, Ji     More...

Wei, CL, Yao, XJ, Jiang, ZB, Wang, YW, Zhang, DZ, Chen, X, Fan, XX, Xie, C, Cheng, JL, Fu, JJ, Leung, ELH     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2019, Volume 144, Pages 79-89

收錄情况： WOS SCOPUS

WOS核心合集引用: 94  2024影響因子:  10.5  发表年影響因子:  5.893 

3.Network pharmacology based investigation into the effect and mechanism of Modified Sijunzi Decoction against the subtypes of chronic atrophic gastritis

Tian, GH, Wu, CH, Li     More...

Tian, GH, Wu, CH, Li, J, Liang, BL, Zhang, FL, Fan, XX, Li, ZW, Wang, YJ, Li, ZH, Liu, D, Leung, ELH, Chen, JX     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2019, Volume 144, Pages 158-166

收錄情况： WOS SCOPUS

WOS核心合集引用: 97  2024影響因子:  10.5  发表年影響因子:  5.893 

4.Long-term efficacy of Chinese medicine Bushen Capsule on cognition and brain activity in patients with amnestic mild cognitive impairment

Zhang, JY, Yang, CS,     More...

Zhang, JY, Yang, CS, Wei, DF, Li, H, Leung, ELH, Deng, QQ, Liu, Z, Fan, XX, Zhang, ZJ     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2019, Volume 146,

收錄情况： WOS SCOPUS

WOS核心合集引用: 35  2024影響因子:  10.5  发表年影響因子:  5.893 

5.Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway

Xie, YaJia, Gao, Wei     More...

Xie, YaJia, Gao, WeiNa, Wu, QiBiao, Yao, XiaoJun, Jiang, ZeBo, Wang, YuWei, Wang, WenJun, Hussain, Shahid, Liu, Liang, Leung, Elaine LaiHan, Fan, XingXing, Li, Wei     Less

Pharmacological Research[1043-6618], Published 2020, Volume 159,

收錄情况： WOS SCOPUS

WOS核心合集引用: 41  2024影響因子:  10.5  发表年影響因子:  7.658 

6.Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8+ T cells

Jiang, ZeBo, Xu, Con     More...

Jiang, ZeBo, Xu, Cong, Wang, Wenjun, Zhang, YiZhong, Huang, JuMin, Xie, YaJia, Wang, QianQian, Fan, XingXing, Yao, XiaoJun, Xie, Chun, Wang, XuanRun, Yan, PeiYu, Ma, YuPo, Wu, QiBiao, Leung, Elaine LaiHan     Less

Pharmacological Research[1043-6618], Published 2021, Volume 169,

收錄情况： WOS SCOPUS

WOS核心合集引用: 45  2024影響因子:  10.5  发表年影響因子:  10.334 

7.Andrographolide suppresses non-small-cell lung cancer progression through induction of autophagy and antitumor immune response

Wang, XR, Jiang, ZB,     More...

Wang, XR, Jiang, ZB, Xu, C, Meng, WY, Liu, P, Zhang, YZ, Xie, C, Xu, JY, Xie, YJ, Liang, TL, Yan, HX, Fan, XX, Yao, XJ, Wu, QB, Leung, ELH     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 179,

收錄情况： WOS SCOPUS

WOS核心合集引用: 82  2024影響因子:  10.5  发表年影響因子:  9.3 

8.Bacteria-based nanodrug for anticancer therapy

Xie, YaJia, Huang, M     More...

Xie, YaJia, Huang, Min, Nasim, Ali Adnan, Huang, JuMin, Xie, Chun, Leung, Elaine LaiHan, Fan, XingXing, Li, Dan, Hou, JinCai, Liang, HaiHai     Less

Pharmacological Research[1043-6618], Published 2022, Volume 182,

收錄情况： WOS SCOPUS

WOS核心合集引用: 23  2024影響因子:  10.5  发表年影響因子:  9.3 

9.Nanotechnology-based chimeric antigen receptor T-cell therapy in treating solid tumor

Zuo, YH, Zhao, XP, F     More...

Zuo, YH, Zhao, XP, Fan, XX     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 184,

收錄情况： WOS SCOPUS

WOS核心合集引用: 25  2024影響因子:  10.5  发表年影響因子:  9.3 

10.Down-regulating Nrf2 by tangeretin reverses multiple drug resistance to both chemotherapy and EGFR tyrosine kinase inhibitors in lung cancer

Xie, Y, Feng, SL, He     More...

Xie, Y, Feng, SL, He, F, Yan, PY, Yao, XJ, Fan, XX, Leung, ELH, Zhou, H     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2022, Volume 186,

收錄情况： WOS SCOPUS

WOS核心合集引用: 37  2024影響因子:  10.5  发表年影響因子:  9.3 

11.ll-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancer

Xu, C, Jiang, ZB, Sh     More...

Xu, C, Jiang, ZB, Shao, L, Zhao, ZM, Fan, XX, Sui, XB, Yu, LL, Wang, XR, Zhang, RN, Wang, WJ, Xie, YJ, Zhang, YZ, Nie, XW, Xie, C, Huang, JM, Wang, J, Wang, J, Leung, ELH, Wu, QB     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2023, Volume 191,

收錄情况： WOS SCOPUS

WOS核心合集引用: 91  2024影響因子:  10.5  发表年影響因子:  9.1 

12.Depletion of regulatory T cells enhancing the anti-tumor effect of in situ vaccination in solid tumors

Xie, YJ, Tian, S, Hu     More...

Xie, YJ, Tian, S, Huang, M, Lu, LL, Liu, ZQ, Chen, JH, Fan, XX     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2024, Volume 203,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2024影響因子:  10.5  发表年影響因子:  10.5 

13.Berbamine as potential STING inhibitor For KRAS-mutant non-small cell lung cancer

Yan, HX, Huang, JM,     More...

Yan, HX, Huang, JM, Wang, YW, Zhang, YZ, Ren, WK, Zhai, ZR, Tang, YP, Lai, HL, Fan, XX, Liu, LH, Leung, ELH     Less

PHARMACOLOGICAL RESEARCH[1043-6618], Published 2025, Volume 216,

收錄情况： WOS SCOPUS

WOS核心合集引用: 3  2024影響因子:  10.5